PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,057,860 | -23.9% | 653,000 | 0.0% | 0.25% | -39.3% |
| Q1 2023 | $1,390,890 | -74.3% | 653,000 | -55.3% | 0.42% | -77.8% |
| Q4 2022 | $5,402,000 | +133.0% | 1,460,000 | -53.1% | 1.88% | +96.2% |
| Q3 2022 | $2,318,000 | +8.8% | 3,115,000 | +13.7% | 0.96% | -0.4% |
| Q2 2022 | $2,131,000 | -2.9% | 2,740,000 | +13.0% | 0.96% | +40.9% |
| Q1 2022 | $2,195,000 | -80.9% | 2,425,000 | +68.9% | 0.68% | -72.0% |
| Q4 2021 | $11,498,000 | -3.5% | 1,435,510 | +0.8% | 2.44% | +9.5% |
| Q3 2021 | $11,921,000 | +28.1% | 1,424,200 | +3.2% | 2.23% | +44.1% |
| Q2 2021 | $9,304,000 | +8.0% | 1,380,400 | +5.9% | 1.54% | +22.1% |
| Q1 2021 | $8,613,000 | – | 1,303,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |